Iovance Biotherapeutics (IOVA) Deferred Taxes (2023 - 2025)
Historic Deferred Taxes for Iovance Biotherapeutics (IOVA) over the last 3 years, with Q3 2025 value amounting to -$2.4 million.
- Iovance Biotherapeutics' Deferred Taxes fell 5811.97% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$696000.0, marking a year-over-year increase of 8867.56%. This contributed to the annual value of -$2.8 million for FY2024, which is 1871.23% up from last year.
- Iovance Biotherapeutics' Deferred Taxes amounted to -$2.4 million in Q3 2025, which was down 5811.97% from $2.0 million recorded in Q2 2025.
- Over the past 5 years, Iovance Biotherapeutics' Deferred Taxes peaked at $2.0 million during Q2 2025, and registered a low of -$2.4 million during Q3 2025.
- In the last 3 years, Iovance Biotherapeutics' Deferred Taxes had a median value of -$1.4 million in 2024 and averaged -$856200.0.
- As far as peak fluctuations go, Iovance Biotherapeutics' Deferred Taxes crashed by 20566.04% in 2024, and later soared by 23635.12% in 2025.
- Quarter analysis of 3 years shows Iovance Biotherapeutics' Deferred Taxes stood at -$1.8 million in 2023, then skyrocketed by 188.63% to $1.6 million in 2024, then crashed by 254.27% to -$2.4 million in 2025.
- Its Deferred Taxes stands at -$2.4 million for Q3 2025, versus $2.0 million for Q2 2025 and -$1.8 million for Q1 2025.